Description and Brand Names
Drug information provided by: IBM Micromedex
US Brand Name
- Kyprolis
Descriptions
Carfilzomib injection is used alone to treat relapsed (cancer that has come back) or refractory (cancer that did not respond to treatment) multiple myeloma (a type of bone marrow cancer) in patients who have received 1 or more previous treatments.
Carfilzomib injection is also used together with other medicines (eg, dexamethasone, daratumumab and dexamethasone, lenalidomide and dexamethasone, and daratumumab and hyaluronidase-fihj and dexamethasone) to treat relapsed or refractory multiple myeloma in patients who have received 1 to 3 previous treatments.
Carfilzomib is an antineoplastic agent (cancer medicine). It interferes with the growth of cancer cells, which are eventually destroyed by the body.
This medicine is to be given only by or under the supervision of your doctor.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2022
Copyright © 2022 IBM Watson Health. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.